Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

[Clinical impact of ertapenem de-escalation in critically-ill patients with Enterobacteriaceae infections].

Cuesta DP, Blanco VM, Vallejo ME, Hernández-Gómez C, Maya JJ, Motoa G, Correa A, Matta L, Rosso F, Camargo RD, Muñoz M, Florez E, Nagles J, Ovalle A, Reyes S, Villegas MV.

Rev Chilena Infectol. 2019 Feb;36(1):9-15. doi: 10.4067/S0716-10182019000100009. Spanish.

2.

Characteristics of inflammatory eye disease associated with hidradenitis suppurativa.

Saygın D, Syed AU, Lowder CY, Srivastava S, Maya JJ, Hajj-Ali RA.

Eur J Rheumatol. 2018 Sep;5(3):165-168. doi: 10.5152/eurjrheum.2018.17163. Epub 2018 Jun 22.

3.

[Prevalence and risk factors for extended-spectrum β-lactamase-producing Escherichia coli causing community-onset urinary tract infections in Colombia].

Blanco VM, Maya JJ, Correa A, Perenguez M, Muñoz JS, Motoa G, Pallares CJ, Rosso F, Matta L, Celis Y, Garzon M, Villegas MV.

Enferm Infecc Microbiol Clin. 2016 Nov;34(9):559-565. doi: 10.1016/j.eimc.2015.11.017. Epub 2016 Jan 13. Spanish.

4.

Dissemination of high-risk clones of extensively drug-resistant Pseudomonas aeruginosa in colombia.

Correa A, Del Campo R, Perenguez M, Blanco VM, Rodríguez-Baños M, Perez F, Maya JJ, Rojas L, Cantón R, Arias CA, Villegas MV.

Antimicrob Agents Chemother. 2015 Apr;59(4):2421-5. doi: 10.1128/AAC.03926-14. Epub 2015 Jan 20.

5.

Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases.

Munoz-Price LS, Poirel L, Bonomo RA, Schwaber MJ, Daikos GL, Cormican M, Cornaglia G, Garau J, Gniadkowski M, Hayden MK, Kumarasamy K, Livermore DM, Maya JJ, Nordmann P, Patel JB, Paterson DL, Pitout J, Villegas MV, Wang H, Woodford N, Quinn JP.

Lancet Infect Dis. 2013 Sep;13(9):785-96. doi: 10.1016/S1473-3099(13)70190-7. Review.

6.

Current status of carbapenemases in Latin America.

Maya JJ, Ruiz SJ, Blanco VM, Gotuzzo E, Guzman-Blanco M, Labarca J, Salles M, Quinn JP, Villegas MV.

Expert Rev Anti Infect Ther. 2013 Jul;11(7):657-67. doi: 10.1586/14787210.2013.811924.

PMID:
23879607
7.

First report of a nonmetallocarbapenemase class A carbapenemase in an Enterobacter cloacae isolate from Colombia.

Blanco VM, Rojas LJ, De La Cadena E, Maya JJ, Camargo RD, Correa A, Quinn JP, Villegas MV.

Antimicrob Agents Chemother. 2013 Jul;57(7):3457. doi: 10.1128/AAC.02425-12. Epub 2013 Apr 22. No abstract available.

8.

Emergence of Klebsiella pneumoniae Coharboring KPC and VIM Carbapenemases in Colombia.

Rojas LJ, Mojica MF, Blanco VM, Correa A, Montealegre MC, De La Cadena E, Maya JJ, Camargo RD, Quinn JP, Villegas MV.

Antimicrob Agents Chemother. 2013 Feb;57(2):1101-2. doi: 10.1128/AAC.01666-12. Epub 2012 Dec 10. No abstract available.

9.

First report of a Pseudomonas aeruginosa isolate coharboring KPC and VIM carbapenemases.

Correa A, Montealegre MC, Mojica MF, Maya JJ, Rojas LJ, De La Cadena EP, Ruiz SJ, Recalde M, Rosso F, Quinn JP, Villegas MV.

Antimicrob Agents Chemother. 2012 Oct;56(10):5422-3. doi: 10.1128/AAC.00695-12. Epub 2012 Jul 23. No abstract available.

10.

Molecular correlates of the spread of KPC-producing Enterobacteriaceae in Colombia.

Mojica MF, Correa A, Vargas DA, Maya JJ, Montealegre MC, Rojas LJ, Ruiz SJ, Quinn JP, Villegas MV; Colombian Nosocomial Bacterial Resistance Study Group.

Int J Antimicrob Agents. 2012 Sep;40(3):277-9. Epub 2012 Jul 11. No abstract available.

PMID:
22789725
11.

First identification of OXA-72 carbapenemase from Acinetobacter pittii in Colombia.

Montealegre MC, Maya JJ, Correa A, Espinal P, Mojica MF, Ruiz SJ, Rosso F, Vila J, Quinn JP, Villegas MV.

Antimicrob Agents Chemother. 2012 Jul;56(7):3996-8. doi: 10.1128/AAC.05628-11. Epub 2012 Apr 16.

Supplemental Content

Support Center